Overcoming ABCB1-mediated multidrug resistance by transcription factor BHLHE40
Yongmei Yin(Nanjing Medical University), Jing Xiong(China Pharmaceutical University), Mengyao Qin(China Pharmaceutical University), Donghao An(China Pharmaceutical University), Xin Yu(Shanghai Clinical Research Center), Feng Zhang(China Pharmaceutical University), Tao Xi(China Pharmaceutical University), Huiqing Fan(Northwestern Polytechnical University), Jinxin Xia(China Pharmaceutical University)
Cited by 8
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
MicroRNA-125b Induces Metastasis by Targeting STARD13 in MCF-7 and MDA-MB-231 Breast Cancer Cells
|PLoS ONE|2012|204
STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling
|Journal of Hematology & Oncology|2018|129